AzTrials
AzTrials

InflammationNCT05034315

Effects of Whole Egg Consumption on Inflammation, Mood, and Recovery in Collegiate Female Gymnasts

A study testing Whole egg consumption in people with Inflammation, run by Iowa State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objectives were to investigate the effects of whole egg consumption by collegiate female gymnasts on inflammatory markers, mood, and recovery. Read more about this study

Who is it for?
Ages 18 to 22 years, women only
Conditions the study is for
Inflammation
What is being tested?
Whole egg consumption
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 siteUnited States
Study dates
1 Jul 2018to 30 Apr 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 22 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Membership on the university gymnastics team

Who cannot join

  • egg allergies, asthma, coronary artery disease, depression, diabetes, hypertension, migraines, cancer or cancer-related complications, or auto-immune disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Iowa State University

    Ames, Iowa, 50011

Other trials in United States

About this study

The objectives were to investigate the effects of whole egg consumption by collegiate female gymnasts on inflammatory markers, mood, and recovery.

Conditions
Inflammation
Being tested
Whole egg consumption
Medical subject headings
Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whole egg consumptionOther

    The participants in the whole egg group consumed two whole eggs immediately after exercise.

Study groups in NCT05034315
Study groupRoleWhat they receive
Whole egg consumptionExperimentalNot described
Receives: Other: Whole egg consumption
No egg controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum C-reactive protein (CRP)

    Measured: 8 months

  2. Serum interleukin-6 (IL-6)

    Measured: 8 months

  3. Serum soluble interleukin-6 receptor (sIL-6R)

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2021
  2. Study start1 Jul 2018
  3. Primary completion30 Apr 2019
  4. Study completion30 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05034315
Sponsor's protocol ID
17-309
Status last verified
Sep 2021
First submitted
24 Aug 2021
Last updated
5 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Whole egg consumption in people with Inflammation, run by Iowa State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum C-reactive protein (CRP) (time frame: 8 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in